AstraZeneca’s NEXIUM receives first regulatory approval in Japan for the treatment of acid-related diseases
1 July 2011 | By AstraZeneca
NEXIUM 10 mg and 20 mg capsules have received regulatory approval in Japan...
List view / Grid view
News
Merck receives approval to market GARDASIL®, ZOLINZA® and CUBICIN®
1 July 2011 | By Merck
Merck announced that the Japanese MHLW approved three products – GARDASIL®, ZOLINZA® and CUBICIN®...
Novartis receives approval in Japan for Onbrez® Inhalation Capsules
1 July 2011 | By Novartis
Novartis has received regulatory approval in Japan for Onbrez® Inhalation Capsules (indacaterol)...
Thermo Fisher Scientific recognised as winner of the 2011 Microsoft Life Sciences Innovation Awards
Thermo Fisher Scientific Inc., the world leader in serving science, today announced that it is a 2011 winner of Microsoft Corporation’s Life Sciences Innovation Awards. This is the fourth consecutive year that the company has been recognized by Microsoft, demonstrating Thermo Fisher’s leading position as a provider of innovative enterprise…
Novartis Phase III study shows once-daily NVA237 is superior to placebo
30 June 2011 | By Novartis
Results from the pivotal Phase III GLOW2 clinical trial show that once-daily NVA237, 50 mcg significantly improved lung function...
Pfizer announces data presentations for investigational compounds in its lung cancer portfolio
29 June 2011 | By Pfizer
Pfizer Inc. will present early and mid-stage data from its lung cancer portfolio...
AstraZeneca and PTC announce strategic oncology drug discovery collaboration
29 June 2011 | By AstraZeneca
AstraZeneca & PTC have entered into an exclusive research collaboration & license agreement...
Tecan launches Tecan Award 2011
29 June 2011 | By kdm communications limited
Tecan announced that entries are now open for the 2011 Tecan Award. The Tecan Award is designed to celebrate the innovation and ingenuity of Tecan’s loyal customers...
Macmillan responds to NICE’s decision not to recommend lung cancer drug
29 June 2011 | By Macmillan Cancer Support
Mike Hobday, Head of Policy at Macmillan Cancer Support, said...
Pfizer files with the FDA for review of Axitinib for patients with advanced RCC
28 June 2011 | By Pfizer
The U.S. FDA has accepted Pfizer’s filing for standard review of axitinib for patients with advanced RCC...
UPS and Merck expand their distribution and logistics agreement
28 June 2011 | By Merck
UPS and Merck, announced that the companies have significantly broadened their existing distribution and logistics agreement...
GSK welcomes external scientists to diseases of the developing world research campus
28 June 2011 | By GlaxoSmithKline
External researchers have begun work in the GlaxoSmithKline ‘open lab’ in Spain...
Gilead Sciences announces agreement with Tibotec Pharmaceuticals
28 June 2011 | By Gilead Sciences, Inc.
Development and commercialization of a new fixed-dose antiretroviral combination product...
Thermo Fisher Scientific announces breakthrough workflow for metabolomics research
Thermo Fisher Scientific Inc., the world leader in serving science, today announced a breakthrough workflow to overcome key analytical and informatics challenges in metabolomics.
Investigational ultra-long-acting insulin degludec reduces hypoglycaemia
27 June 2011 | By Novo Nordisk
Ultra-long-acting insulin degludec, lowers blood glucose levels with significantly reduced rates of hypoglycaemia (low blood sugar)...
